Deals Of The Week: Shire/arGEN-X/Ethris, Evotec/Yale, Amgen/Bind Biosciences

 
• By Wendy Diller, Paul Bonanos, Jessica Merrill, and Sten Stovall

GSK’s venture arm outlines its investment priorities, which involve changes to the biopharma business model.

More from Archive

More from Pink Sheet